181 related articles for article (PubMed ID: 10712432)
41. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
[TBL] [Abstract][Full Text] [Related]
42. Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function.
Rao H; Lu G; Kajiya H; Garcia-Palacios V; Kurihara N; Anderson J; Patrene K; Sheppard D; Blair HC; Windle JJ; Choi SJ; Roodman GD
J Bone Miner Res; 2006 Oct; 21(10):1657-65. PubMed ID: 16995821
[TBL] [Abstract][Full Text] [Related]
43. Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice.
Blin-Wakkach C; Breuil V; Quincey D; Bagnis C; Carle GF
Bone; 2006 Jul; 39(1):53-60. PubMed ID: 16503212
[TBL] [Abstract][Full Text] [Related]
44. Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone.
Sundaram K; Shanmugarajan S; Rao DS; Reddy SV
Endocrinology; 2011 Nov; 152(11):4180-9. PubMed ID: 21878516
[TBL] [Abstract][Full Text] [Related]
45. Pathobiology of Paget's Disease of Bone.
Galson DL; Roodman GD
J Bone Metab; 2014 May; 21(2):85-98. PubMed ID: 25025000
[TBL] [Abstract][Full Text] [Related]
46. CFU-GM-derived cells form osteoclasts at a very high efficiency.
Menaa C; Kurihara N; Roodman GD
Biochem Biophys Res Commun; 2000 Jan; 267(3):943-6. PubMed ID: 10673396
[TBL] [Abstract][Full Text] [Related]
47. Canine distemper virus induces human osteoclastogenesis through NF-kappaB and sequestosome 1/P62 activation.
Selby PL; Davies M; Mee AP
J Bone Miner Res; 2006 Nov; 21(11):1750-6. PubMed ID: 17002577
[TBL] [Abstract][Full Text] [Related]
48. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
Lee SK; Lorenzo JA
Endocrinology; 1999 Aug; 140(8):3552-61. PubMed ID: 10433211
[TBL] [Abstract][Full Text] [Related]
49. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.
Roodman GD; Kurihara N; Ohsaki Y; Kukita A; Hosking D; Demulder A; Smith JF; Singer FR
J Clin Invest; 1992 Jan; 89(1):46-52. PubMed ID: 1729280
[TBL] [Abstract][Full Text] [Related]
50. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.
Matsuzaki K; Udagawa N; Takahashi N; Yamaguchi K; Yasuda H; Shima N; Morinaga T; Toyama Y; Yabe Y; Higashio K; Suda T
Biochem Biophys Res Commun; 1998 May; 246(1):199-204. PubMed ID: 9600092
[TBL] [Abstract][Full Text] [Related]
51. The effect on chick osteoclasts of infection with paramyxoviruses.
Shepard SL; Cooper RJ; McClure J
J Pathol; 1996 Aug; 179(4):448-52. PubMed ID: 8869296
[TBL] [Abstract][Full Text] [Related]
52. Role of ascorbic acid in the osteoclast formation: induction of osteoclast differentiation factor with formation of the extracellular collagen matrix.
Otsuka E; Kato Y; Hirose S; Hagiwara H
Endocrinology; 2000 Aug; 141(8):3006-11. PubMed ID: 10919289
[TBL] [Abstract][Full Text] [Related]
53. Activation of osteoclasts by interleukin-1: divergent responsiveness in osteoclasts formed in vivo and in vitro.
Fox SW; Fuller K; Chambers TJ
J Cell Physiol; 2000 Sep; 184(3):334-40. PubMed ID: 10911364
[TBL] [Abstract][Full Text] [Related]
54. Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget's disease of bone.
Reddy SV; Menaa C; Singer FR; Cundy T; Cornish J; Whyte MP; Roodman GD
Exp Hematol; 1999 Oct; 27(10):1528-32. PubMed ID: 10517494
[TBL] [Abstract][Full Text] [Related]
55. Abnormalities in osteoclast precursors and marrow accessory cells in Paget's disease.
Demulder A; Takahashi S; Singer FR; Hosking DJ; Roodman GD
Endocrinology; 1993 Nov; 133(5):1978-82. PubMed ID: 7691583
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease.
Hoyland JA; Freemont AJ; Sharpe PT
J Bone Miner Res; 1994 Jan; 9(1):75-80. PubMed ID: 8154312
[TBL] [Abstract][Full Text] [Related]
57. A Novel Reliable and Efficient Procedure for Purification of Mature Osteoclasts Allowing Functional Assays in Mouse Cells.
Madel MB; Ibáñez L; Rouleau M; Wakkach A; Blin-Wakkach C
Front Immunol; 2018; 9():2567. PubMed ID: 30450105
[TBL] [Abstract][Full Text] [Related]
58. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation.
Nagai M; Sato N
Biochem Biophys Res Commun; 1999 Apr; 257(3):719-23. PubMed ID: 10208850
[TBL] [Abstract][Full Text] [Related]
59. Osteoclast function in Paget's disease and multiple myeloma.
Roodman GD
Bone; 1995 Aug; 17(2 Suppl):57S-61S. PubMed ID: 8579899
[TBL] [Abstract][Full Text] [Related]
60. c-myc is required for osteoclast differentiation.
Battaglino R; Kim D; Fu J; Vaage B; Fu XY; Stashenko P
J Bone Miner Res; 2002 May; 17(5):763-73. PubMed ID: 12009006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
